SG Americas Securities’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Sell |
20,282
-501,984
| -96% | -$14.4M | ﹤0.01% | 1417 |
|
|
2025
Q1 | $17.5M | Sell |
522,266
-20,180
| -4% | -$677K | 0.06% | 204 |
|
|
2024
Q4 | $27.7M | Buy |
542,446
+529,483
| +4,085% | +$27.1M | 0.11% | 84 |
|
|
2024
Q3 | $662K | Sell |
12,963
-66,088
| -84% | -$3.38M | ﹤0.01% | 1266 |
|
|
2024
Q2 | $3.54M | Buy |
79,051
+73,084
| +1,225% | +$3.27M | 0.02% | 647 |
|
|
2024
Q1 | $279K | Buy |
+5,967
| New | +$279K | ﹤0.01% | 1544 |
|
|
2023
Q2 | – | Sell |
-26,166
| Closed | -$420K | – | 2124 |
|
|
2023
Q1 | $420K | Buy |
26,166
+16,399
| +168% | +$263K | ﹤0.01% | 1694 |
|
|
2022
Q4 | $179K | Sell |
9,767
-5,559
| -36% | -$102K | ﹤0.01% | 2066 |
|
|
2022
Q3 | $301K | Sell |
15,326
-10,066
| -40% | -$198K | ﹤0.01% | 1771 |
|
|
2022
Q2 | $474K | Buy |
+25,392
| New | +$474K | 0.01% | 1822 |
|
|
2022
Q1 | – | Sell |
-6,366
| Closed | -$181K | – | 2652 |
|
|
2021
Q4 | $181K | Sell |
6,366
-12,901
| -67% | -$367K | ﹤0.01% | 2459 |
|
|
2021
Q3 | $406K | Buy |
+19,267
| New | +$406K | ﹤0.01% | 2470 |
|
|
2020
Q3 | – | Sell |
-14,802
| Closed | -$259K | – | 2308 |
|
|
2020
Q2 | $259K | Buy |
+14,802
| New | +$259K | ﹤0.01% | 2260 |
|